In lung cancer cells, the disruption of iron metabolism is characterized by upregulation of iron transport proteins such as transferrin (Tf) and hepcidin, while the expression of ferroportin, an iron export protein, is reduced (Figure 1). The gene discussed is TF; the disease is lung carcinoma.